ArticleBlood advances2023
Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis.
Bethany Verkamp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it